Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis

Publisher： Karger

E-ISSN： 1662-680x|5|2|130-134

ISSN： 1662-680x

Source： Case Reports in Neurology, Vol.5, Iss.2, 2013-07, pp. : 130-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein Alleles and the Response to Interferon-β-1b in Multiple Sclerosis

By  

European Neurology, Vol. 65, Iss. 3, 2011-02 ,pp. : 132-137

Karger

Access to resources Recommend Favorite

Electrophysiological, Neuropsychological and Clinical Findings in Multiple Sclerosis Patients Receiving Interferon β-1b: A 1-Year Follow-Up

By  

European Neurology, Vol. 44, Iss. 4, 2000-11 ,pp. : 205-209

Karger

Access to resources Recommend Favorite

Effects of Interferon-β1a on the Hypothalamic-Pituitary-Adrenal Axis, Leukocyte Distribution and Mood States in Multiple Sclerosis Patients

By  

European Neurology, Vol. 53, Iss. 4, 2005-07 ,pp. : 182-187

Karger

Access to resources Recommend Favorite

Interferon-β1b in Multiple Sclerosis: Effect on Progression of Disability and Clinical Markers of Treatment Response

By  

European Neurology, Vol. 60, Iss. 6, 2008-09 ,pp. : 279-284

Karger

Access to resources Recommend Favorite

Azathioprine and Interferon β1a in Relapsing-Remitting Multiple Sclerosis Patients: Increasing Efficacy of Combined Treatment

By  

European Neurology, Vol. 51, Iss. 1, 2004-01 ,pp. : 15-20

Karger

Access to resources Recommend Favorite